Posted by Clinical Lab Products | Oct 22, 2010 | Cancer, Molecular Diagnostics, Research |
Cancer tests based on detecting DNA changes and patterns will show above average revenue growth over other forms of testing, according to health care market research publisher Kalorama Information.
Read MorePosted by Clinical Lab Products | Sep 14, 2010 | Miscellaneous |
Myconostica Ltd presented positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the Companys CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples.
Read MorePosted by Clinical Lab Products | Jul 20, 2010 | Miscellaneous |
The FDA can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way, according to the American Clinical Laboratory Association.
Read MorePosted by Clinical Lab Products | Jun 9, 2010 | Miscellaneous |
Biomerica Inc announced that it has purchased a patented technology and the manufacturing rights for a new Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of developing severe side effects.
Read MorePosted by Clinical Lab Products | Apr 22, 2010 | Cancer, Miscellaneous |
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read More